skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.02d (Release date: 2016-02-27)
SearchBox Top
SearchBox Bottom
ABVD Regimen (Code C9509)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: ABVD Regimen

Definition: A chemotherapy regimen consisting of doxorubicin hydrochloride (Adriamycin), bleomycin, vinblastine and dacarbazine, used alone or in combination with radiation therapy, for the primary treatment of Hodgkin lymphoma.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine.

Display Name: ABVD Regimen

Label: ABVD Regimen

NCI Thesaurus Code: C9509 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0050380  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
ABVD
ABVD Regimen
ABVD regimen
Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen
BLEO/DOX/DTIC/VBL
Bleomycin/Dacarbazine/Doxorubicin/Vinblastine

External Source Codes: 
PDQ Closed Trial Search ID 39364
PDQ Open Trial Search ID 39364 (check for NCI PDQ open clinical trial info)
UMLS CUI C0050380

Other Properties:
Name Value (qualifiers indented underneath)
code C9509
Contributing_Source CTRP
Legacy_Concept_Name Bleomycin_Dacarbazine_Doxorubicin_Vinblastine
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C9509

Mainbox Bottom